Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirk U Knowlton

Showing results (101-110 of 132) with videos related to

Pageof 14
Sort By:
American Heart Journal|June 8, 2023
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLEKamal Gupta, Harsh Mehta, Hwasoon Kim, et al.
Contemporary Clinical Trials|July 27, 2025
Association of study visit interval length with follow-up completeness and adherence to assigned study drug dose: A randomized comparison of participants in the ADAPTABLE trialDennis I Narcisse, Jeff Whittle, Grace M Rhodes, et al.
Plos Medicine|July 7, 2025
Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trialsKirk U Knowlton, Lianne K Siegel, Christina E Barkauskas, et al.
Journal of the American Heart Association|February 13, 2024
Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular DiseaseGuillaume Marquis-Gravel, Amanda Stebbins, Lisa M Wruck, et al.
Mayo Clinic Proceedings|May 3, 2023
Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control LaboratoryAlanna M Chamberlain, Rhonda M Cooper-DeHoff, Valy Fontil, et al.
Communications Biology|October 8, 2021
A genome-wide meta-analysis uncovers six sequence variants conferring risk of vertigoAstros Th Skuladottir, Gyda Bjornsdottir, Muhammad Sulaman Nawaz, et al.
Communications Biology|April 26, 2024
GWAS meta-analysis reveals key risk loci in essential tremor pathogenesisAstros Th Skuladottir, Lilja Stefansdottir, Gisli H Halldorsson, et al.
Cell|September 15, 2023
Complex effects of sequence variants on lipid levels and coronary artery diseaseAudunn S Snaebjarnarson, Anna Helgadottir, Gudny A Arnadottir, et al.
Nature Genetics|January 19, 2023
Genome-wide meta-analysis identifies 93 risk loci and enables risk prediction equivalent to monogenic forms of venous thromboembolismJonas Ghouse, Vinicius Tragante, Gustav Ahlberg, et al.
Human Molecular Genetics|December 1, 2025
Observational and Mendelian randomization studies of plasma sclerostin levels do not provide evidence of cardiovascular adverse effects of sclerostin inhibitionRosa B Thorolfsdottir, Gardar Sveinbjornsson, Grimur Hjorleifsson Eldjarn, et al.
Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
American Heart Journal|June 8, 2023
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLEKamal Gupta, Harsh Mehta, Hwasoon Kim, et al.
Contemporary Clinical Trials|July 27, 2025
Association of study visit interval length with follow-up completeness and adherence to assigned study drug dose: A randomized comparison of participants in the ADAPTABLE trialDennis I Narcisse, Jeff Whittle, Grace M Rhodes, et al.
Plos Medicine|July 7, 2025
Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trialsKirk U Knowlton, Lianne K Siegel, Christina E Barkauskas, et al.
Journal of the American Heart Association|February 13, 2024
Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular DiseaseGuillaume Marquis-Gravel, Amanda Stebbins, Lisa M Wruck, et al.
Mayo Clinic Proceedings|May 3, 2023
Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control LaboratoryAlanna M Chamberlain, Rhonda M Cooper-DeHoff, Valy Fontil, et al.
Communications Biology|October 8, 2021
A genome-wide meta-analysis uncovers six sequence variants conferring risk of vertigoAstros Th Skuladottir, Gyda Bjornsdottir, Muhammad Sulaman Nawaz, et al.
Communications Biology|April 26, 2024
GWAS meta-analysis reveals key risk loci in essential tremor pathogenesisAstros Th Skuladottir, Lilja Stefansdottir, Gisli H Halldorsson, et al.
Cell|September 15, 2023
Complex effects of sequence variants on lipid levels and coronary artery diseaseAudunn S Snaebjarnarson, Anna Helgadottir, Gudny A Arnadottir, et al.
Nature Genetics|January 19, 2023
Genome-wide meta-analysis identifies 93 risk loci and enables risk prediction equivalent to monogenic forms of venous thromboembolismJonas Ghouse, Vinicius Tragante, Gustav Ahlberg, et al.
Human Molecular Genetics|December 1, 2025
Observational and Mendelian randomization studies of plasma sclerostin levels do not provide evidence of cardiovascular adverse effects of sclerostin inhibitionRosa B Thorolfsdottir, Gardar Sveinbjornsson, Grimur Hjorleifsson Eldjarn, et al.
Pageof 14